IMAX Corporation (IMAX) Income Statement

The 12.2% growth in 2026Q2 follows a 3.1% increase in 2025Q2 and a 16.6% jump in 2025Q3, indicating a volatile but generally upward trend. However, the 6.1% contraction in 2026Q1 suggests that without major tentpole releases, revenue can quickly decelerate. Given that Greater China historically contributes over 25% of revenue, any regulatory or consumer spending shifts there could disproportionately impact top-line growth. Investors should monitor the installation backlog and filmed-for-IMAX capture rate as leading indicators of future revenue durability.

The 440 basis point year-over-year gross margin improvement in 2026Q2 indicates that the company is benefiting from a greater proportion of recurring revenue streams, such as joint revenue sharing arrangements and DMR fees. However, gross margins have ranged from 49.4% to 63.1% over the past ten quarters, highlighting sensitivity to system sales timing and film performance. The structural shift toward JRSAs may sustain higher margins but also introduces variability tied to box office results. Compared to peers like Cinemark (18.6% gross margin), IMAX's 57.9% average gross margin underscores its asset-light, IP-driven model.

SG&A expenses have stayed between $31.4M and $37.7M over the past ten quarters, while revenue has ranged from $79.1M to $125.2M. This stability demonstrates high operating leverage, where incremental revenue from box office hits translates disproportionately to operating income. For instance, 2025Q4 revenue of $125.2M produced $32.3M operating income, whereas 2024Q2 revenue of $89.0M yielded only $2.9M. The 2026Q2 operating margin of 20.2% is below the 27.2% achieved in 2025Q3, suggesting that cost pressures or mix changes may be dampening leverage. Investors should watch whether SG&A growth accelerates as the company invests in new initiatives like IMAX Enhanced.

The reduction in COGS margin suggests improved efficiency in hardware production or a shift toward higher-margin revenue streams. SG&A has been remarkably stable, hovering around $33-36M per quarter, which indicates disciplined overhead management despite revenue fluctuations. R&D spending has been modest, averaging $1.5M per quarter, which may be low for a technology-driven company but reflects the maturity of its core platform. The 2026Q2 operating margin of 20.2% is below the 27.2% peak in 2025Q3, but the year-over-year improvement from 16.9% is encouraging. However, the recent EPS miss suggests that cost pressures may be emerging in areas not fully captured by these line items, such as tax or minority interest.

The 35.1% revenue growth in 2025Q4 was the strongest in the ten-quarter period, likely driven by a major blockbuster slate. However, the net margin of just 0.5% versus an operating margin of 25.8% suggests that significant one-time charges, tax adjustments, or impairments occurred. This quarter underscores the importance of looking beyond revenue and operating income to understand true profitability. The subsequent quarters (2026Q1 and Q2) show a recovery in net margins to 5.2% and 15.0%, respectively, but the volatility remains a concern. Investors should scrutinize the footnotes for the 2025Q4 net income anomaly to assess whether it signals recurring issues or a one-off event.